Moore, K. T., & Langas, M. (2018). Use of Rivaroxaban and Apixaban, Two Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), in Renally Impaired Patients - the limits of our knowledge. Journal of Cardiology and Cardiovascular Medicine, 3(3), 049–051. https://doi.org/10.29328/journal.jccm.1001026